Last reviewed · How we verify
NCT02949505
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation
NA trial testing Home prehabilitation program in Liver Cirrhosis in 18 participants. Completed in 1 August 2018.
1 October 2017
Quick facts
| Lead sponsor | Matthew Armstrong |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 1 March 2017 |
| Primary completion | 1 October 2017 |
| Estimated completion | 1 August 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Home prehabilitation program
Conditions studied
- Liver Cirrhosis — all drugs for Liver Cirrhosis →
- Liver Dysfunction — all drugs for Liver Dysfunction →
Sponsor
Matthew Armstrong
Who can join
Adults 18 to 75, any sex, with Liver Cirrhosis or Liver Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A UK prospective, single-centre feasibility study investigating the effects of exercise therapy on functional capacity in patients on the waiting list for liver transplantation. Patients will receive a 12-week home prehabilitation program (daily step program; functional resistance exercise sessions; telephone health call or virtual clinic). The following will be assessed at weeks 0, 6 and 12 weeks: feasibility (recruitment, compliance, safety, patients perception), functional capacity (ISWT, SPBT), psychological wellbeing (HADS questionnaire) and quality of life (EQ-5D)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Home-based exercise therapy in patients awaiting liver transplantation: protocol for an observational feasibility trial.
Williams FR, Vallance A, Faulkner T, Towey J, et al · · 2018 · cited 13× · PMID 29358444 · DOI 10.1136/bmjopen-2017-019298
Verify or expand the search:
- PubMed search for NCT02949505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Cirrhosis
Currently open trials in the same condition.
- NCT07439939 — Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Place · recruiting
- NCT07325526 — A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- · Phase 2 · recruiting
- NCT07418008 — The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) · recruiting
- NCT07201649 — Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcificati · NA · recruiting
- NCT07252102 — Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02949505 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Matthew Armstrong
- Last refreshed: 7 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02949505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing